Table 2. Summary of somatic genetic mutations and rearrangements detected by next-generation sequencing assay and results of MCL1 IHC staining.
| Patient no. | KRAS mutation | GNAS mutation | Other mutations | MCL1 IHC staining | No. of genetic alterations |
|---|---|---|---|---|---|
| 1 | G12D | R201H | Moderate | 2 | |
| 2 | A59T | hMLH1 micro satellite instability | Moderate | 1a | |
| 3 | G12V | R201C | Amplification of MCL1 and JUN | Weak | 4 |
| 4 | G12D | Weak | 1 | ||
| 5 | G12A | Amplification of ZNF703 | Moderate | 2 | |
| 6 | None detected | Moderate to strong | 0 | ||
| 7 | None detected | Moderate to strong | 0 | ||
| 8 | G12D | R201H | Amplification of MCL1 and JUN | Moderate | 4 |
| 9 | Amplification of MCL1, MYC, JUN and NFKBIA | Moderate | 4 | ||
| 10 | G12D | R201C | Moderate to strong | 2 |
Abbreviation: IHC, immunohistochemical.
The hMLH1 microsatellite instability was not counted.